2004
DOI: 10.1007/s00213-004-2036-y
|View full text |Cite
|
Sign up to set email alerts
|

Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats

Abstract: Results indicate that activation of alpha-2 adrencoceptors is involved in both stress-induced reinstatement of alcohol seeking and alcohol self-administration. To the degree that the present results are relevant to human alcoholism, alpha-2 adrencoceptor agonists should be considered in the treatment of alcohol dependence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
104
3

Year Published

2007
2007
2015
2015

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 232 publications
(117 citation statements)
references
References 65 publications
7
104
3
Order By: Relevance
“…The fact that two different pharmacologic interventions that decrease noradrenergic signaling, but via different mechanisms, are both capable of suppressing alcohol drinking is consistent with evidence that activation of the noradrenergic system plays a key role in mediating voluntary alcohol drinking. These results are also consistent with reports that: a) the α 2 -adrenergic receptor agonist, lofexidine, reduces operant self-administration of alcohol by Wistar rats (Lé, Harding, Juzytsch, Funk, & Shaham, 2005), b) clonidine and another α 2 -adrenergic receptor agonist, guanfacine, decrease alcohol drinking by food-restricted rats selectively bred for alcohol drinking (descendants of the Finnish Alko Alcohol (AA) rats) (Opitz, 1990), c) depletion of brain norepinephrine decreases alcohol drinking (Amit, Brown, Levitan, & Ogren, 1977; Brown et al, 1977) and alcohol self-administration in unselected rats (Davis et al, 1978), and d) prazosin reduces acute withdrawal-induced operant self-administration of alcohol by alcohol-dependent Wistar rats (Walker, Rasmussen, Raskind, & Koob, 2008). …”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…The fact that two different pharmacologic interventions that decrease noradrenergic signaling, but via different mechanisms, are both capable of suppressing alcohol drinking is consistent with evidence that activation of the noradrenergic system plays a key role in mediating voluntary alcohol drinking. These results are also consistent with reports that: a) the α 2 -adrenergic receptor agonist, lofexidine, reduces operant self-administration of alcohol by Wistar rats (Lé, Harding, Juzytsch, Funk, & Shaham, 2005), b) clonidine and another α 2 -adrenergic receptor agonist, guanfacine, decrease alcohol drinking by food-restricted rats selectively bred for alcohol drinking (descendants of the Finnish Alko Alcohol (AA) rats) (Opitz, 1990), c) depletion of brain norepinephrine decreases alcohol drinking (Amit, Brown, Levitan, & Ogren, 1977; Brown et al, 1977) and alcohol self-administration in unselected rats (Davis et al, 1978), and d) prazosin reduces acute withdrawal-induced operant self-administration of alcohol by alcohol-dependent Wistar rats (Walker, Rasmussen, Raskind, & Koob, 2008). …”
Section: Discussionsupporting
confidence: 93%
“…For example, clonidine decreases craving, anxiety, tension, irritability, and restlessness associated with nicotine withdrawal (Glassman et al, 1984). More recently, administration of clonidine or other α 2 -adrenergic receptor agonists (e.g., lofexidine, guanfacine, guanabenz) has been demonstrated to attenuate stress-induced reinstatement of opiate, cocaine, and alcohol seeking in rats (Erb et al, 2000; Highfield, Yap, Grimm, Shalev, & Shaham, 2001; Lé et al, 2005; Shaham et al, 2000). These results are consistent with evidence that blocking post-synaptic α 1 -adrenergic receptors with prazosin decreases consumption of cocaine, opiates, nicotine, and alcohol (Greenwell, Walker, Cottone, Zorrilla, & Koob, 2009; Rasmussen et al, 2009; Simpson et al, 2009; Villégier, Lotfipour, Belluzzi, & Leslie, 2007; Wee, Mandyam, Lekic, & Koob, 2008; Zhang & Kosten, 2005, 2007) and with the findings of the current study that inhibiting noradrenergic signaling with the α 2 -adrenergic receptor agonist, clonidine, decreases voluntary alcohol consumption.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, duloxetine may decrease anxiety-related ethanol intake by attenuating LC output via activation of presynaptic α2-ARs, which act as autoreceptors in this region. In support of this, SNRIs have been shown to decrease LC output (Berrocoso and Mico, 2007), and α2-AR agonists are reported to reduce ethanol self-administration (Le et al, 2005). Further work is needed to determine how noradrenergic signaling is disrupted by chronic adolescent stress and subsequent ethanol intake, and where in the brain these pharmacotherapeutics are exerting their effects on stress-related voluntary ethanol consumption.…”
Section: Discussionmentioning
confidence: 84%
“…In rats, administration of propranolol, a beta-adrenergic receptor antagonist, reduced operant responding for alcohol (Gilpin and Koob, 2010). Moreover, increasing NE transmission via inactivation of presynaptic alpha-2 adrenergic autoreceptors potentiates reinstatement of EtOH self-administration, while activating this receptor attenuates EtOH drinking (Le et al, 2005). Furthermore, prazosin, an alpha-1 adrenergic receptor antagonist, reduces EtOH drinking in alcohol-dependent (Walker et al, 2008) and -preferring rats (Verplaetse et al, 2012), and reduces stress-induced reinstatement of alcohol seeking in rats (Le et al, 2011).…”
Section: Discussionmentioning
confidence: 99%